Phase I dose-escalation study of tenecteplase, a third-generation fibrinolytic agent, combined with neuronavigation-assisted stereotactic minimally invasive puncture, in patients with acute spontaneous deep cerebral haemorrhageZhiyou Wu, Yong Cao, Jinyi Tang et al.|Stroke and Vascular Neurology|2025Cited by 0